Hai‐Jiao Yang

RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression

Zhenyu Liu, Ming Zheng, Yiming Li et al. · Theranostics · 2019 · 89 citations · Full text

Medicine, Immunology, Oncology +17

Receptor‐Interacting Protein Kinase 3 Deficiency Recruits Myeloid‐Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C‐X‐C Motif) Ligand 1–Chemokine (C‐X‐C Motif) Receptor 2 Axis

Yiming Li, Zhenyu Liu, Jian‐Chao Wang et al. · Hepatology · 2019 · 74 citations · Full text

Medicine, Cancer Biology, Oncology +17

Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer

Yiming Li, Jingmin Yu, Zhenyu Liu et al. · International Journal of Molecular Sciences · 2019 · 33 citations · Full text

Medicine, Immunology, Oncology +17

CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia

Nai-Shan Zheng, Xiangyu Zhao, Jinlin Miao et al. · Cancer Letters · 2022 · 24 citations

Life Sciences, Immunology, Oncology +12

UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL

Renyu Zhang, C. Li, Shuai Zhang et al. · Clinical and Molecular Hepatology · 2024 · 24 citations · Full text

Life Sciences, Biochemistry, Oncology +17